The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Precision diabetes: learning from monogenic diabetes
Open accessAbstract
The precision medicine approach of tailoring treatment to the individual characteristics of each patient or subgroup has been a great success in monogenic diabetes subtypes, MODY and neonatal diabetes. This review examines what has led to the success of a precision medicine approach in monogenic diabetes (precision diabetes) and outlines possible implications for type 2 diabetes. For monogenic diabetes, the molecular genetics can define discrete aetiological subtypes that have profound implications on diabetes treatment and can predict future development of associated clinical features, allowing early preventative or supportive treatment. In contrast, type 2 diabetes has overlapping polygenic susceptibility and underlying aetiologies, making it difficult to define discrete clinical subtypes with a dramatic implication for treatment. The implementation of precision medicine in neonatal diabetes was simple and rapid as it was based on single clinical criteria (diagnosed <6 months of age). In contrast, in MODY it was more complex and slow because of the lack of single criteria to identify patients, but it was greatly assisted by the development of a diagnostic probability calculator and associated smartphone app. Experience in monogenic diabetes suggests that successful adoption of a precision diabetes approach in type 2 diabetes will require simple, quick, easily accessible stratification that is based on a combination of routine clinical data, rather than relying on newer technologies. Analysing existing clinical data from routine clinical practice and trials may provide early success for precision medicine in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
Blundell, J. E., Baker, J. L., Boyland, E., Blaak, E., Charzewska, J., de Henauw, S., Frühbeck, G., Gonzalez-Gross, M., Hebebrand, J., Holm, L., et al. (2017) · Obesity Facts · doi:10.1159/000455952 · Cited by 1,945
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Self-citationThe genetic architecture of type 2 diabetes
Fuchsberger, C., Flannick, J., Teslovich, T. M., Mahajan, A., Agarwala, V., Gaulton, K. J., Ma, C., Fontanillas, P., Moutsianas, L., McCarthy, D. J., et al. (2016) · Nature · doi:10.1038/nature18642 · Cited by 1,051
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988 · cited 2×
“without an increase in hypoglycaemia and glucose variability [9].”
BackgroundSelf-citationMutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S., Stoffel, M., & Bell, G. I. (1996) · Nature · doi:10.1038/384458a0 · Cited by 976
Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY
Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B. N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-384 · Cited by 880
Maturity-onset diabetes of the young (MODY): how many cases are we missing?
Shields, B. M., Hicks, S., Shepherd, M. H., Colclough, K., Hattersley, A. T., & Ellard, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1799-4 · Cited by 725
Self-citationThe many faces of diabetes: a disease with increasing heterogeneity
Tuomi, T., Santoro, N., Caprio, S., Cai, M., Weng, J., & Groop, L. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62219-9 · Cited by 652
Froguel, P., Vaxillaire, M., Sun, F., Velho, G., Zouali, H., Butel, M. O., Lesage, S., Vionnet, N., Clément, K., Fougerousse, F., et al. (1992) · Nature · doi:10.1038/356162a0 · Cited by 630
Bennett, W. L., Maruthur, N. M., Singh, S., Segal, J. B., Wilson, L. M., Chatterjee, R., Marinopoulos, S. S., Puhan, M. A., Ranasinghe, P., Block, L., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00336 · Cited by 609 · cited 1×
“On average, most glucose lowering therapies for type 2 diabetes reduce HbA1c by about 1% (11 mmol/mol) [53].”
BackgroundGenetic cause of hyperglycaemia and response to treatment in diabetes
Pearson, E. R., Starkey, B. J., Powell, R. J., Gribble, F. M., Clark, P. M., & Hattersley, A. T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14571-0 · Cited by 607
Self-citationActivating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
Flanagan, S. E., Haapaniemi, E., Russell, M. A., Caswell, R., Allen, H. L., De Franco, E., McDonald, T. J., Rajala, H., Ramelius, A., Barton, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.3040 · Cited by 508
Self-citationClinical implications of a molecular genetic classification of monogenic β-cell diabetes
Murphy, R., Ellard, S., & Hattersley, A. T. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0778 · Cited by 502
Self-citationActivating Mutations in Kir6.2 and Neonatal Diabetes
Hattersley, A. T., & Ashcroft, F. M. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2503 · Cited by 414
Self-citationPihoker, C., Gilliam, L. K., Ellard, S., Dabelea, D., Davis, C., Dolan, L. M., Greenbaum, C. J., Imperatore, G., Lawrence, J. M., Marcovina, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1279 · Cited by 397
Self-citationSteele, A. M., Shields, B. M., Wensley, K. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · JAMA · doi:10.1001/jama.2013.283980 · Cited by 381
Self-citationLinkage of type 2 diabetes to the glucokinase gene
Hattersley, A. T., Turner, R. C., Patel, P., O'Rahilly, S., Hattersley, A. T., Patel, P., Wainscoat, J. S., Permutt, M. A., Tanazawa, Y., Chin, K. C., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)91958-b · Cited by 375
Self-citationMild Familial Diabetes with Dominant Inheritance
(1974) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067391 · Cited by 354
De Franco, E., Flanagan, S. E., Houghton, J. A., Allen, H. L., Mackay, D. J., Temple, I. K., Ellard, S., & Hattersley, A. T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60098-8 · Cited by 349
Self-citationShields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., & Hattersley, A. T. (2012) · Diabetologia · doi:10.1007/s00125-011-2418-8 · Cited by 335
Self-citationPermanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2
Sagen, J. V., Ræder, H., Hathout, E., Shehadeh, N., Gudmundsson, K., Bævre, H., Abuelo, D., Phornphutkul, C., Molnes, J., Bell, G. I., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2713 · Cited by 333
Self-citationImproved genetic testing for monogenic diabetes using targeted next-generation sequencing
Ellard, S., Lango Allen, H., De Franco, E., Flanagan, S. E., Hysenaj, G., Colclough, K., Houghton, J. A. L., Shepherd, M., Hattersley, A. T., Weedon, M. N., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2962-5 · Cited by 307
Self-citationChakera, A. J., Steele, A. M., Gloyn, A. L., Shepherd, M. H., Shields, B., Ellard, S., & Hattersley, A. T. (2015) · Diabetes Care · doi:10.2337/dc14-2769 · Cited by 289
Self-citationPearson, E. R., Liddell, W. G., Shepherd, M., Corrall, R. J., & Hattersley, A. T. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00305.x · Cited by 259
Self-citationPainting a new picture of personalised medicine for diabetes
McCarthy, M. I. (2017) · Diabetologia · doi:10.1007/s00125-017-4210-x · Cited by 255
Shepherd, M., Shields, B., Hammersley, S., Hudson, M., McDonald, T. J., Colclough, K., Oram, R. A., Knight, B., Hyde, C., Cox, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0645 · Cited by 236 · cited 2×
“This gene panel testing approach identifies approximately an additional 25% of monogenic patients with less common causes compared with selected testing of common genetic subtypes [23].”
BackgroundSelf-citationPearson, E. R., Pruhova, S., Tack, C. J., Johansen, A., Castleden, H. A. J., Lumb, P. J., Wierzbicki, A. S., Clark, P. M., Lebl, J., Pedersen, O., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1738-y · Cited by 232
Self-citationMcDonald, T. J., Colclough, K., Brown, R., Shields, B., Shepherd, M., Bingley, P., Williams, A., Hattersley, A. T., & Ellard, S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03287.x · Cited by 229
Self-citationStride, A., Shields, B., Gill-Carey, O., Chakera, A. J., Colclough, K., Ellard, S., & Hattersley, A. T. (2014) · Diabetologia · doi:10.1007/s00125-013-3075-x · Cited by 212
Self-citationThe biochemical assessment of insulin resistance
Borai, A., Livingstone, C., & Ferns, G. A. A. (2007) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456307780945778 · Cited by 184
Jones, A. G., McDonald, T. J., Shields, B. M., Hill, A. V., Hyde, C. J., Knight, B. A., & Hattersley, A. T. (2016) · Diabetes Care · doi:10.2337/dc15-0258 · Cited by 178
Self-citationGloyn, A. L., Diatloff-Zito, C., Edghill, E. L., Bellanné-Chantelot, C., Nivot, S., Coutant, R., Ellard, S., Hattersley, A. T., & Robert, J. J. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201629 · Cited by 159
Self-citationPermanent diabetes mellitus in the first year of life
and the Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology, Iafusco, D., Stazi, M. A., Cotichini, R., Cotellessa, M., Martinucci, M., Mazzella, M., Cherubini, V., Barbetti, F., Martinetti, M., et al. (2002) · Diabetologia · doi:10.1007/s00125-002-0837-2 · Cited by 159
Naylor, R. N., John, P. M., Winn, A. N., Carmody, D., Greeley, S. A. W., Philipson, L. H., Bell, G. I., & Huang, E. S. (2013) · Diabetes Care · doi:10.2337/dc13-0410 · Cited by 149
Learning From Molecular Genetics
McCarthy, M. I., & Hattersley, A. T. (2008) · Diabetes · doi:10.2337/db08-0343 · Cited by 147
Self-citationContrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations
Pearson, E. R., Badman, M. K., Lockwood, C. R., CLARK, P. M. S., Ellard, S., Bingham, C., & Hattersley, A. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1102 · Cited by 147
Self-citationHattersley, A. T., Bruining, J., Hamilton-Shield, J. P., Njølstad, P. R., & Donaghue, K. C. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00217.x · Cited by 139
Self-citationBesser, R. E. J., Shepherd, M. H., McDonald, T. J., Shields, B. M., Knight, B., Ellard, S., & Hattersley, A. T. (2011) · Diabetes Care · doi:10.2337/dc10-1293 · Cited by 137
Self-citationFlannick, J., Beer, N. L., Bick, A. G., Agarwala, V., Molnes, J., Gupta, N., Burtt, N. P., Florez, J. C., Meigs, J. B., Taylor, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2794 · Cited by 136
Spyer, G., MacLeod, K. M., Shepherd, M. H., Ellard, S., & Hattersley, A. T. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02622.x · Cited by 128
Self-citationEdghill, E. L., Dix, R. J., Flanagan, S. E., Bingley, P. J., Hattersley, A. T., Ellard, S., & Gillespie, K. M. (2006) · Diabetes · doi:10.2337/db06-0094 · Cited by 124
Self-citationStandardization of C-peptide measurements
Little, R. R., Rohlfing, C. L., Tennill, A. L., Madsen, R. W., Polonsky, K. S., Myers, G. L., Greenbaum, C. J., Palmer, J. P., Rogatsky, E., & Stein, D. T. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101287 · Cited by 103 · cited 1×
“are not standardised between laboratories [50, 51].”
Beltrand, J., Elie, C., Busiah, K., Fournier, E., Boddaert, N., Bahi‐Buisson, N., Vera, M., Quoc, E. B., Ingster-Moati, I., Berdugo, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0837 · Cited by 98
The Cost-Effectiveness of Personalized Genetic Medicine
Greeley, S. A. W., John, P. M., Winn, A. N., Ornelas, J., Lipton, R. B., Philipson, L. H., Bell, G. I., & Huang, E. S. (2011) · Diabetes Care · doi:10.2337/dc10-1616 · Cited by 92
Tattersall, R. B., & Fajans, S. S. (1975) · Diabetes · doi:10.2337/diab.24.5.452 · Cited by 80
Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues
Parfitt, C., Church, D., Armston, A. E., Couchman, L., Evans, C., Wark, G., & McDonald, T. J. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.07.017 · Cited by 78
KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life
Rubio‐Cabezas, O., Flanagan, S. E., Damhuis, A., Hattersley, A. T., & Ellard, S. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00824.x · Cited by 77
Self-citationCounterregulatory responses to hypoglycemia in patients with glucokinase gene mutations.
Guenat, E., Seematter, G., Philippé, J., Temler, E., Jéquier, E., & Tappy, L. (2000) · PubMed · Cited by 53
The Common p.R114W HNF4A Mutation Causes a Distinct Clinical Subtype of Monogenic Diabetes
Laver, T. W., Colclough, K., Shepherd, M. H., Patel, K. A., Houghton, J., Dušátková, P., Průhová, Š., Morris, A. D., Palmer, C. N., McCarthy, M. I., et al. (2016) · Diabetes · doi:10.2337/db16-0628 · Cited by 53
Self-citationCompensation in Pancreatic β-Cell Function in Subjects With Glucokinase Mutations
Sturis, J., Kurland, I. J., Byrne, M. M., Mosekilde, E., Froguel, P., Pilkis, S. J., Bell, G. I., & Polonsky, K. S. (1994) · Diabetes · doi:10.2337/diab.43.5.718 · Cited by 51
Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
Pearson, E. R., Dawed, A. Y., & Zhou, K. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s84854 · Cited by 49
Awa, W. L., Thon, A., Raile, K., Grulich‐Henn, J., Meissner, T., Schober, E., Holl, R. W., & _, _. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0842 · Cited by 43
Nademi, Z., Slatter, M. A., Gambineri, E., Mannurita, S. C., Barge, D., Hodges, S., Bunn, S. K., Thomas, J., Haugk, B., Hambleton, S., et al. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.181 · Cited by 40
Iafusco, D., Bizzarri, C., Cadario, F., Pesavento, R., Tonini, G., Tumini, S., Cauvin, V., Colombo, C., Bonfanti, R., & Barbetti, F. (2011) · Diabetologia · doi:10.1007/s00125-011-2273-7 · Cited by 36
Cited by
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Dennis, J. M., Shields, B. M., Henley, W. E., Jones, A. G., & Hattersley, A. T. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30087-7 · Cited by 462
Self-citationChung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0022 · Cited by 400
Wright, C. F., West, B., Tuke, M., Jones, S. E., Patel, K., Laver, T. W., Beaumont, R. N., Tyrrell, J., Wood, A. R., Frayling, T. M., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.12.015 · Cited by 212
Self-citation
Metadata
- Authors
- Hattersley, A. T., & Patel, K. A.
- Venue
- Diabetologia
- Published
- 2017-03-17
- Volume
- 60
- Issue
- 5
- Pages
- 769-777
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2596992715
- Cited by
- 306
- References
- 55
- FWCI
- 18.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.